Abstract
Manufacture by aseptic processing accompanied by end product compendial sterility testing has been the predominant means of production and disposition of therapeutics requiring the critical quality attribute of sterility. Despite significant advancements in microbiology and epidemiology and innovations in therapeutic products and engineering, there have been minimal advancements in the standards and regulations governing the assurance of sterility. Furthermore, the assurance of sterility of current and future therapies are not well served in a singular fashion, rather therapies occupy optimal locations in a sterility assurance design space within which parametric release is the default and expected mode of product disposition. Indeed, recent chimeric antigen receptor T-cell therapies (CART) for all intents and purposes conform to the principles and requirements for parametric release; its disposition is parametric in all but words. This article offers a new direction including a “road map” for the future of sterility assurance paved through a sequence of ongoing changes to the United States Pharmacopeia (USP) informational chapters. The future state of design-space provides optimal assurance of sterility and expanded opportunities for parametric release is explored by introduction of candidate modalities for sterile manufacture per recently revised USP <1211> and <1222>.
- © PDA, Inc. 2022
PDA members receive access to all articles published in the current year and previous volume year. Institutional subscribers received access to all content. Log in below to receive access to this article if you are either of these.
If you are neither or you are a PDA member trying to access an article outside of your membership license, then you must purchase access to this article (below). If you do not have a username or password for JPST, you will be required to create an account prior to purchasing.
Full issue PDFs are for PDA members only.
Note to pda.org users
The PDA and PDA bookstore websites (www.pda.org and www.pda.org/bookstore) are separate websites from the PDA JPST website. When you first join PDA, your initial UserID and Password are sent to HighWirePress to create your PDA JPST account. Subsequent UserrID and Password changes required at the PDA websites will not pass on to PDA JPST and vice versa. If you forget your PDA JPST UserID and/or Password, you can request help to retrieve UserID and reset Password below.